-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Walking impairment in patients with multiple sclerosis: exercise training as a treatment option
Review
(2180) Views (715) Full article downloads
Authors: Robert W Motl, Myla D Goldman, Ralph HB Benedict
Published Date November 2010
Volume 2010:6(1) Pages 767 - 774
DOI: http://dx.doi.org/10.2147/NDT.S10480
Robert W Motl1, Myla D Goldman2, Ralph HB Benedict31Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL, USA; 2Department of Neurology, University of Virginia, VA, USA; 3Department of Neurology, SUNY Buffalo School of Medicine, Buffalo, NY, USA
Abstract: Multiple sclerosis (MS) is a chronic disease of the central nervous system that culminates in the progression of physical and cognitive disability over time. Walking impairment is a ubiquitous feature of MS and a sentinel characteristic of the later or advanced stages of the disease. This paper presents a conceptual rationale along with empirical evidence for exercise training as a rehabilitation approach for managing walking impairment and improving walking function in persons with MS. Conceptually, MS is associated with a decrease in physical activity, which, in turn, can result in deconditioning across multiple domains of physiological functioning. The resulting deconditioning feeds back and further drives physical inactivity until a threshold is reached that likely initiates the progression of walking impairment in MS. Empirically, physical activity and exercise training have been associated with beneficial effects on walking function in persons with MS. This is based on cross-sectional, longitudinal, and experimental research that included diversity in the breadth of measures of walking, persons with MS, and exercise/physical activity characteristics. Of particular importance, future researchers might consider examining the combinatory effects of exercise training plus pharmacological agents on walking mobility in MS. Collectively, exercise training and physical activity might hold significant potential for the management of progressive mobility disability in MS.
Keywords: mobility, walking, exercise, physical activity, movement
Readers of this article also read:
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
Disease-modifying therapies in relapsing–remitting multiple sclerosis
ABO and rhesus blood group distribution in Kurds
Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
Neurocognitive impairment after off-pump and on-pump coronary artery bypass graft surgery – an Iranian experience
Functional imaging of hippocampal dysfunction among persons with Alzheimer’s disease: a proof-of-concept study
Hyperbaric oxygen ameliorates worsening signs and symptoms of post-traumatic stress disorder
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
- Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety
- Moderate alcohol consumption and cognitive risk
- Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference




